ThePolitibase
H.R. 2343In CommitteeHEALTH

John W. Walsh Alpha-1 Home Infusion Act of 2025

Sponsor
Rep. Salazar, Maria Elvira [R-FL-27]
R · FL-27
Key facts
Introduced: Mar 25, 2025
Chamber: House
Cosponsors: 52
Congress: 119th
Latest action · Mar 25, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summary

John W. Walsh Alpha-1 Home Infusion Act of 2025

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Summary by Congressional Research Service.

Timeline

  1. Mar 25, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  2. Mar 25, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. Mar 25, 2025
    Introduced in House
  4. Mar 25, 2025
    Introduced in House

Cosponsors (showing first 30 of 52)

In the News

View official record on Congress.gov →